Sanofi-Aventis U.S. LLC v. Apotex Corp.
1:15-cv-00044
Overview
Parties
Defendant
Plaintiff
Sanofi Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Aventis Pharma S.A. NPE (Individual / Inventor)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Sanofi-Aventis U.S. LLC Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 5,847,170 Asserted | Asserted Patent | View Official Patent → |
| πΊπΈ United States | US 6,331,635 B1 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 6,372,780 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 6,387,946 B1 | US Continuation / Sibling | View Official Patent → |
| π«π· France | FR 9503545 A | France Counterpart | View Official Patent → |
| π«π· France | FR 2732340 B1 | France Counterpart | View Official Patent → |
| π«π· France | FR 9515381 A | France Counterpart | View Official Patent → |
| π«π· France | FR 2742754 B1 | France Counterpart | View Official Patent → |
| πΊπΈ United States | US 1,014,496 P | US Continuation / Sibling | View Official Patent → |
Neptune Generics, LLC et al. v. Aventis Pharma S.A. et al.
Mylan Laboratories Limited et al. v. Aventis Pharma S.A. et al.
SANOFI-AVENTIS U.S. LLC v. MYLAN LABORATORIES LIMITED
Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA LLC
SANOFI-AVENTIS U.S. LLC v. ACCORD HEALTHCARE, INC.
SANOFI-AVENTIS U.S. LLC v. FRESENIUS KABI USA, LLC
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5847170
Taxoids, their preparation and pharmaceutical compositions containing them
|
Filed: 1996-03-26
Issued: 1998-12-08
|
Expired (Term Ended)
+1826d PTA
Expires: 2021-03-26
|
|
|
US7241907
Acetone solvate of dimethoxy docetaxel and its process of preparation
|
Filed: 2004-09-17
Issued: 2007-07-10
|
Expired (Term Ended)
+449d PTA
Expires: 2025-12-10
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+1826 days) / Cellect Scrutiny β Over 1826 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).